Published August 24, 2018
| Version v1
Poster
Open
Understanding the pathogenic mechanism of ACVR1 mutations in Diffuse Intrinsic Pontine Glioma
- 1. SGC, University of Oxford
- 2. 0000-0002-1407-2529
Description
A research poster outlining the planned experiments and preliminary results of a research project titled 'Understanding the pathogenic mechanism of ACVR1/ALK2 mutations in Diffuse Intrinsic Pontine Glioma (DIPG)'. The subheadings include BMP signalling mechanisms, epigenetic screening, migration assays and CRISPR-Cas9 knockout of mutant ACVR1.
Notes
Funding Acknowledgment: The SGC is a registered charity (number 1097737) that receives funds from AbbVie, Bayer Pharma AG, Boehringer Ingelheim, Canada Foundation for Innovation, Eshelman Institute for Innovation, Genome Canada through Ontario Genomics Institute [OGI-055], Innovative Medicines Initiative (EU/EFPIA) [ULTRA-DD grant no. 115766], Janssen, Merck KGaA, Darmstadt, Germany, MSD, Novartis Pharma AG, Ontario Ministry of Research, Innovation and Science (MRIS), Pfizer, São Paulo Research Foundation-FAPESP, Takeda, and Wellcome.
Files
Understanding the pathogenic mechanism of ACVR1 mutations in DIPG_DPhil day poster_Elizabeth Brown.pdf
Files
(1.1 MB)
| Name | Size | Download all |
|---|---|---|
|
md5:696bb98d94f7e9dfc4b6bd9740c87c41
|
1.1 MB | Preview Download |